Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma

NCT06045195 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Cologne